CovCIFDock: Covalent Induced Fit Docking With QM/MM

ABSTRACT Although non‐covalent inhibitors represent the majority of approved and investigational drug therapeutics, targeted covalent inhibitors (TCIs) are increasingly being considered due to a greater potency and higher selectivity. Many currently available commercial programs excel at modeling non‐covalent inhibitors. However, many of these non‐covalent docking programs are unsuitable for docking TCIs because they do not model the post‐reaction protein–ligand structure. Attempts to modify existing methods or formulate new ones that can simulate covalent docking often utilize classical mechanical potentials that inherently lack the ability to modulate bonding topologies in an effort to reduce computational overhead. Not only are such modifications ill‐suited to covalent docking, they can lead to a reduction in docking accuracy and impose limitations on the transferability of a method to other protein systems. Herein we aim to address these shortcomings by utilizing a hybrid simulation workflow that employs both classical and quantum mechanical (QM/MM) potentials capable of bond rearrangement. The workflow, named CovCIFDock, is an extension of the recently published CHARMM‐based induced fit docking (CIFDock) method. Protein–ligand complexes are docked classically in the pre‐reactive state in order to facilitate computational speed, after which a QM/MM minimization is conducted to form the protein–ligand bond and refine the final pose. CovCIFDock was validated against 46 protein receptors belonging to Cathepsin K, HCV NS3, EGFR, and XPO1 targets. It is able to replicate the binding mode (ligand heavy‐atom RMSD 2 Å) of these TCI complexes for 76% of complexes in the validation set, with an average RMSD of 1.87 Å, and is comparable to the 74% success rate reported for Schrödinger's CovDock on the same dataset.

Authors

Institutions

Publication Details

Journal
Journal of Computational Chemistry
Published
2026-11-17
DOI
https://doi.org/10.1002/jcc.70541
Citations
2
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CovCIFDock: Covalent Induced Fit Docking With QM/MM

Luke C. Warrensford, H. Lee Woodcock, Amanda Pittman
2 citations
Journal of Computational Chemistry
Computational Drug Discovery Methods
1.31
article

CovCIFDock: Covalent Induced Fit Docking With QM/MM

Luke C. Warrensford, H. Lee Woodcock, Amanda Pittman
article en
2 citations

Abstract

ABSTRACT Although non‐covalent inhibitors represent the majority of approved and investigational drug therapeutics, targeted covalent inhibitors (TCIs) are increasingly being considered due to a greater potency and higher selectivity. Many currently available commercial programs excel at modeling non‐covalent inhibitors. However, many of these non‐covalent docking programs are unsuitable for docking TCIs because they do not model the post‐reaction protein–ligand structure. Attempts to modify existing methods or formulate new ones that can simulate covalent docking often utilize classical mechanical potentials that inherently lack the ability to modulate bonding topologies in an effort to reduce computational overhead. Not only are such modifications ill‐suited to covalent docking, they can lead to a reduction in docking accuracy and impose limitations on the transferability of a method to other protein systems. Herein we aim to address these shortcomings by utilizing a hybrid simulation workflow that employs both classical and quantum mechanical (QM/MM) potentials capable of bond rearrangement. The workflow, named CovCIFDock, is an extension of the recently published CHARMM‐based induced fit docking (CIFDock) method. Protein–ligand complexes are docked classically in the pre‐reactive state in order to facilitate computational speed, after which a QM/MM minimization is conducted to form the protein–ligand bond and refine the final pose. CovCIFDock was validated against 46 protein receptors belonging to Cathepsin K, HCV NS3, EGFR, and XPO1 targets. It is able to replicate the binding mode (ligand heavy‐atom RMSD 2 Å) of these TCI complexes for 76% of complexes in the validation set, with an average RMSD of 1.87 Å, and is comparable to the 74% success rate reported for Schrödinger's CovDock on the same dataset.

Journal of Computational ChemistryVol. 47(31)
University of South Florida (US), New College of Florida (US)
University of South Florida, National Institutes of Health, National Institute of General Medical Sciences
Openalex Percentile: Top 24%
Computational Drug Discovery Methods
1.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon